News from GlySens

2016
Date
News
11.10.16

GlySens Incorporated Shares Recent Data and Market Insights of the Long Term, Fully Implantable Glucose Monitoring System

Bethesda, MD – November 10, 2016 – GlySens Incorporated executives, Bill Markle and Joseph Lucisano, PhD presented separate findings at the 16 th annual Diabetes Technology Society meeting. This conference brings together leading scientific researchers and health care professionals from around the world to focus […]
10.04.16

Patient Enrollment and Implantation Procedures Complete for FIGS-2 Trial

San Diego, CA – October 4, 2016 – GlySens Incorporated today announced the successful implantation of the twentieth human subject participating in the Function of Implanted Glucose Sensor 2 (FIGS-2) trial [Clinicaltrials.gov NCT02345967] for people with diabetes in the United States. The FIGS-2 study is […]
07.06.16

GlySens Discusses its Long Term Fully Implantable Glucose Monitoring System at 4 th Annual NIH Artificial Pancreas Workshop

Bethesda, MD – July 6, 2016 – GlySens Incorporated’s presentation entitled “Continuous, Long-term, Fully Implanted Glucose Sensor” was discussed today by Dr. Joseph Lucisano, the Company’s founder and CTO, at the “Fourth Artificial Pancreas Workshop.” This event, held at the National Institutes of Health (NIH) […]
03.14.16

Successful Re-implantation of the Eclipse™ ICGM® Sensor in Sixth Clinical Trial Participant

San Diego, CA – March 14, 2016 – GlySens Incorporated today completed the successful re-implantation of the Eclipse™ ICGM® Sensor in a sixth human subject participating in the Function of Implanted Glucose Sensor 2 (FIGS-2) trial [Clinicaltrials.gov NCT02345967] for people with diabetes in the United […]
01.05.16

GlySens Incorporated Secures $20M Series D Investment

SAN DIEGO, Jan. 5, 2016 – GLYSENS INCORPORATED announced today that it has closed a $20M Series D financing led by prior investors from its Series C round, in addition to significant participation from new investors. “The clinical performance of our fully implanted ICGM® system, now with multiple patients […]
Date
News
11.21.14

GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health

SAN DIEGO, CA – November 21, 2014 – GLYSENS INCORPORATED announced today that it has been awarded a two-year, two million dollar grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health (NIH).  The grant […]
07.04.14

GlySens-UCSD collaborative research leads to key findings regarding the viability of long term implanted devices

SAN DIEGO, CA – July 4, 2014 – Important research findings were published today regarding GLYSENS INCORPORATED’s collaborative efforts with Professor David Gough’s Biosensor Research Lab at the University of California, San Diego.  The publication, in the journal Biomaterials, is entitled “Permeability of subcutaneous tissues surrounding […]
04.02.14

GlySens Incorporated featured in MedCity News

SAN DIEGO, CA – April 2, 2014 – GLYSENS INCORPORATED is profiled in a feature article in today”s edition of MedCity News by author Karen Heyman, entitled, “No more needles: Startup tests implant that can measure blood sugar for up to a year.” Several times every […]
Date
News
11.21.14

GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health

SAN DIEGO, CA – November 21, 2014 – GLYSENS INCORPORATED announced today that it has been awarded a two-year, two million dollar grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health (NIH).  The grant […]
07.04.14

GlySens-UCSD collaborative research leads to key findings regarding the viability of long term implanted devices

SAN DIEGO, CA – July 4, 2014 – Important research findings were published today regarding GLYSENS INCORPORATED’s collaborative efforts with Professor David Gough’s Biosensor Research Lab at the University of California, San Diego.  The publication, in the journal Biomaterials, is entitled “Permeability of subcutaneous tissues surrounding […]
04.02.14

GlySens Incorporated featured in MedCity News

SAN DIEGO, CA – April 2, 2014 – GLYSENS INCORPORATED is profiled in a feature article in today”s edition of MedCity News by author Karen Heyman, entitled, “No more needles: Startup tests implant that can measure blood sugar for up to a year.” Several times every […]
Date
News
08.28.13

GlySens Incorporated’s recent developments are discussed in a feature story in today’s San Diego Union-Tribune

GlySens Incorporated's recent developments are discussed in a feature story in today’s San Diego Union-Tribune
06.18.13

GlySens named as Finalist in the 2013 San Diego Business Journal Innovation Awards

San Diego, CA – June 18, 2013 – GLYSENS INCORPORATED joined a handful of companies in the Medical Device category honored as finalists in the 2013 San Diego Business Journal Innovation Awards. The awards program was created by the San Diego Business Journal to recognize […]
04.10.13

GlySens Discusses its Long Term Fully Implantable Glucose Monitoring System at NIH Artificial Pancreas Conference

Bethesda, MD – April 10, 2013 – GLYSENS INCORPORATED’S presentation entitled “Long Term, Fully-Implanted, Self-Contained Subcutaneous Glucose Sensor: Results from Clinical Evaluation and Applicability for Closed Loop Systems” was delivered today by Dr. Joseph Lucisano, the Company’s president and CEO, at the “Workshop on Innovation […]
Date
News
11.08.12

GlySens Presents Results of Human Feasibility Study at the Annual Diabetes Technology Meeting

Burlingame, CA – November 8, 2012 – GLYSENS INCORPORATED presented results today of the recently completed first human feasibility trial of its long term, fully implantable continuous glucose monitoring (ICGM) system.  The trial evaluated the Company’s first generation fully-implanted sensors in six individuals with diabetes […]
09.12.12

West Health Investment Fund invests in GlySens

West Health Investment Fund invests in GlySens and RxAnte Startups demonstrate innovative technologies to lower the cost of health care in the treatment of diabetes and medication adherence SAN DIEGO, CA. – Sept. 12, 2012 – The West Health Investment Fund, West Health’s fund focused […]
05.01.12

GlySens Incorporated featured in Scientific American

SAN DIEGO, CA – May 1, 2012 – GLYSENS INCORPORATED is featured in the May 2012 issue of Scientific American, in an article entitled “Smart Implantable Devices”. In the article, author Katherine Harmon reports: “A new implantable glucose sensor made by GlySens in San Diego […]
No press releases
Date
News
07.29.10

GlySens Incorporated profiled by the San Diego Union-Tribune

SAN DIEGO, CA – July 29, 2010 – GLYSENS INCORPORATED is profiled in a front-page story in today’s San Diego Union-Tribune by Staff Writer Keith Darcé, entitled, “SD company hopes monitor will revolutionize diabetes care.” A small San Diego medical device company and a UCSD […]
07.28.10

GlySens’ Implantable Sensor Capable of Long-term Monitoring of Tissue Glucose in Animals

RESEARCH ARTICLE | BIOENGINEERING AND DIABETES Function of an Implanted Tissue Glucose Sensor for More than 1 Year in Animals David A. Gough, Lucas S. Kumosa, Timothy L. Routh, Joe T. Lin and Joseph Y. Lucisano Sci Transl Med 28 July 2010: Vol. 2, Issue 42, p. 42ra53 Sci. […]
07.28.10

GlySens Incorporated First-Generation Sensor Progress reported in Popular Science

SAN DIEGO, CA – July 28, 2010 – Results achieved with the GLYSENS INCORPORATED first-generation implantable glucose monitoring system are reported by author Lauren Gravitz in an article entitled “Wireless, Implantable Glucose Sensor Could Revolutionize Diabetes Treatment,” in this week’s online edition of Popular Science. […]
Date
News
09.01.09

GlySens Incorporated is recognized as a New California 100 Business Innovator by Golden Capital Network & Hamilton Lane

SAN DIEGO, CA – September 1, 2009 – GLYSENS INCORPORATED has been recognized as a New California 100 Innovative Business by Golden Capital Network and Hamilton Lane. New California 100 businesses are some of the most innovative companies in the state representing California’s commitment to […]
Date
News
11.14.08

GlySens Presentation Voted Best Submission at the Eighth Annual Diabetes Technology Meeting

Bethesda, MD – November 14, 2008 – GLYSENS INCORPORATED’S presentation entitled “Long-term Results of a Subcutaneous Glucose Sensor in Animals” was selected as the Best Submission at the eighth annual meeting of the Diabetes Technology Society. The annual meeting, held this year November 13-15 at […]